Huang XY - Search Results

1

Targeting cyclin-dependent kinase 9 in cancer therapy.

Shen YL, Wang YM, Zhang YX, Ma SJ, Yang LH, Zhao CG, Huang XY. Shen YL, et al. Among authors: huang xy. Acta Pharmacol Sin. 2022 Jul;43(7):1633-1645. doi: 10.1038/s41401-021-00796-0. Epub 2021 Nov 22. Acta Pharmacol Sin. 2022. PMID: 34811514 Free PMC article. Review.

2

Puerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells.

Chen C, Chen C, Wang Z, Wang L, Yang L, Ding M, Ding C, Sun Y, Lin Q, Huang X, Du X, Zhao X, Wang C. Chen C, et al. PLoS One. 2012;7(3):e34181. doi: 10.1371/journal.pone.0034181. Epub 2012 Mar 23. PLoS One. 2012. PMID: 22457823 Free PMC article.

3

Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.

Zheng H, Yang L, Kang Y, Chen M, Lin S, Xiang Y, Li C, Dai X, Huang X, Liang G, Zhao C. Zheng H, et al. Mol Carcinog. 2019 Apr;58(4):565-576. doi: 10.1002/mc.22951. Epub 2019 Jan 4. Mol Carcinog. 2019. PMID: 30520143

4

Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.

Yang L, Lin S, Kang Y, Xiang Y, Xu L, Li J, Dai X, Liang G, Huang X, Zhao C. Yang L, et al. J Exp Clin Cancer Res. 2019 Jan 23;38(1):31. doi: 10.1186/s13046-018-1015-9. J Exp Clin Cancer Res. 2019. PMID: 30674340 Free PMC article.

5

Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway.

Yang L, Li J, Xu L, Lin S, Xiang Y, Dai X, Liang G, Huang X, Zhu J, Zhao C. Yang L, et al. Cancer Manag Res. 2019 Feb 1;11:1167-1176. doi: 10.2147/CMAR.S171517. eCollection 2019. Cancer Manag Res. 2019. PMID: 30774444 Free PMC article.

6

Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway.

Xu L, Qiu S, Yang L, Xu H, Liu X, Fan S, Cui R, Fu W, Zhao C, Shen L, Wang L, Huang X. Xu L, et al. Mol Carcinog. 2019 Aug;58(8):1512-1525. doi: 10.1002/mc.23038. Epub 2019 May 8. Mol Carcinog. 2019. PMID: 31069881

7

Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy.

Lin S, Yang L, Yao Y, Xu L, Xiang Y, Zhao H, Wang L, Zuo Z, Huang X, Zhao C. Lin S, et al. J Exp Clin Cancer Res. 2019 Jul 8;38(1):293. doi: 10.1186/s13046-019-1303-z. J Exp Clin Cancer Res. 2019. PMID: 31287013 Free PMC article.

8

Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.

Fu Y, Su L, Cai M, Yao B, Xiao S, He Q, Xu L, Yang L, Zhao C, Wan T, Shao L, Wang L, Huang X. Fu Y, et al. Mol Carcinog. 2019 Nov;58(11):2026-2039. doi: 10.1002/mc.23095. Epub 2019 Aug 9. Mol Carcinog. 2019. PMID: 31397502 Free PMC article.

9

Novel activators and small-molecule inhibitors of STAT3 in cancer.

Yang L, Lin S, Xu L, Lin J, Zhao C, Huang X. Yang L, et al. Cytokine Growth Factor Rev. 2019 Oct;49:10-22. doi: 10.1016/j.cytogfr.2019.10.005. Epub 2019 Oct 22. Cytokine Growth Factor Rev. 2019. PMID: 31677966 Free article. Review.

10

Down-regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle-related genes.

Yu C, Yang L, Cai M, Zhou F, Xiao S, Li Y, Wan T, Cheng D, Wang L, Zhao C, Huang X. Yu C, et al. J Cell Mol Med. 2020 Jan;24(2):1568-1577. doi: 10.1111/jcmm.14844. Epub 2019 Nov 28. J Cell Mol Med. 2020. PMID: 31778025 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,525 results

Search Page

Filters